Trial site
Centrum Medyczne Medyk Sp. z o.o.
- 28running trials
- 12closed trials
The trials here
What the 40 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis16 trials
- Crohn's disease10 trials
- Multiple sclerosis5 trials
- Atrial fibrillation2 trials
- Obesity2 trials
- Prostate cancer2 trials
- Type 2 diabetes2 trials
- Chronic kidney disease1 trial
- Heart failure1 trial
- Metastatic breast cancer1 trial
- Pompe disease1 trial
- Phase
- Phase 321 trials
- Phase 214 trials
- Phase 2/32 trials
- Phase 42 trials
- Phase 11 trial
- Status
- Active, not recruiting19 trials
- Completed12 trials
- Recruiting5 trials
- Not yet recruiting4 trials
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- Hoffmann-La Roche5 trials
- AstraZeneca3 trials
- Novo Nordisk A/S3 trials
- Takeda3 trials
- and 17 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Not yet recruiting
Recruiting
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Active, not recruiting
Study of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis4 recruiting
- Crohn's disease3 recruiting
- Multiple sclerosis2 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Completed
Completed
Completed
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
Completed
Completed
Completed
Active, not recruiting
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026